products – 第 2 页

ACN Newswire

Peijia Medical Announces 2022 Interim Results: TaurusOne(R) and TaurusElite(R) Repeatedly Sets New Monthly Highs in Implantation Volume

August 22, 2022

HONG KONG, Aug 22, 2022 - (ACN Newswire via SEAPRWire.com) - Peijia Medical Limited ("Peijia Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 9996), a leading domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets in China, announced its interim results for the six months ended June 30, 2022 (the "Period").Performance Summary:-- Revenue was RMB118.8 million, representing an increase of 129.8% from the same period of 2021.-- Gross profit (excluding the amortization cost from purchase price allocation) was RMB87.6 million, representing an increase of 133.5% from the same period in 2021, and gross margin (excluding the amortization cost from purchase price allocation) reached 73.7%.Key Operational Statistics:-- Even under the impact of Covid-19, revenue from theTranscatheter Valve Therapeutic Business and Neurointerventional Business were RMB52.1 million and RMB66.7 million, representing an increase of 455.4% and 57.6% from the same period in 2021, respectively.-- For the Transcatheter Valve Therapeutic Business, both product adoption by new hospitals and the utilization rate of its products in the adopted hospitals exceeded expectation. As of July 31, 2022, within a short period of about one year after TaurusOne(R) and TaurusElite(R) received NMPA approvals, a total of 209 hospitals were entered and the implantation volume repeatly reached monthly highs, accounting for close to 20% of the market share in July. The total implantation volume of the six months ended June 30, 2022 has far exceeded that of the whole year of 2021. The pipeline for the Transcatheter Valve Therapeutic Business was progressing smoothly as scheduled.-- The Group's registration applications of four ischemic products have been approved by the NMPA, and the product portfolio for the ischemic product line has been preliminarily established. The Group can provide a complete set of solutions for hemorrhagic and ischemic stokes. In the first half of 2022, the Group continued expanding its share in the sizable hemorrhagic market, constantly consolidating its leading position in the neurointerventional industry. -- The Group made continuous efforts to optimize the supply chain and optimize the production process to achieve long-term success, and continued to maintain stable production to meet the rapid sales demand growth in the first half of the year.During the period, the Group recorded a revenue of RMB118.8 million, representing an increase of 129.8% as compared to the same period in 2021. Revenue from the Transcatheter Valve Therapeutic Business and Neurointerventional Business were RMB52.1 million and RMB66.7 million , representing a substantial increase of 455.4% and 57.6% as compared to the same period in 2021, respectively. The increase in revenue was primarily attributable to: (i) commercialization of the second-generation retrievable TAVR product TaurusElite(R); (ii) increased sales revenue from existing neurointerventional products including Tethys(R) Intermediate Catheter and SacSpeed(R) Balloon Dilation Catheter; and (iii) commercialization of multiple new neurointerventional products including Jasper(R) SS Detachable Coil, etc. Gross profit (excluding the amortization cost from purchase price allocation) was RMB87.6 million, representing an increase of 133.5% from the same period in 2021, and gross margin (excluding the amortization cost from purchase price allocation) reached 73.7%. The impact of Covid-19 in the first half of 2021 further validated the Group's execution capability and operational efficiency. Both business lines exceeded their respective commercialization targets. The Group's pipeline projects progressed smoothly and its production operation and supply chain were well managed. Production fulfillment rate of core products reached around 60% (50% as the baseline) in the first half of the year.Transcatheter Valve Therapeutic business: The commercialization platform was preliminarily established, setting up a strong foundation for commercialization success. Pipeline products also progressed smoothly, bringing sustainability to the long-term business development.For the Transcatheter Valve Therapeutic Business, the Group had five registered products and nine product candidates at various development stages. The sales of TaurusOne(R) and TaurusElite(R) products were in good progress. The revenue of the Transcatheter Valve Therapeutic Business increased by 455.4% as compared to the same period in 2021 despite the impact of the pandemic. As of June 30, 2022, the Group had a sales and marketing team of 151 employees dedicated to the sales and marketing of its Transcatheter Valve Therapeutic Business. Thanks to its outstanding product performance and professional market education and promotion, both product adoption by new hospitals and the utilization rate of our products in the adopted hospitals have accelerated for our Transcatheter Valve Therapeutic Business. As of July 31, 2022, the products of the Group entered 209 hospitals, repeatedly setting new monthly highs in implantation volume. The implantation volume reached close to a market share of 20% in July. For the seven months ended July 31, 2022, the total implantation volume reached close to 650 units, more than twice the implantation volume for the whole year 2021. The second half of the year started with strong momentum. The Group are steadily increasing our market share and striving to outperform other players. The Group have become the top player in certain cities and hospitals, with huge development potential.The Transcatheter Valve Therapeutic Business has progressed rapidly since its commercial launch, thanks to its cross functional teams comprised of marketing, sales and medical professionals. The all-round support ranges from academic promotion to new technology cooperation, from patient identification to physician training, and from preoperative, intraoperative and postoperative clinical support to meticulous sales service. The rapid development of commercialization has built a solid cash foundation for the long-term development of the Company.The Group has developed a competitive product pipeline through external acquisitions and internal development, with a wide range of innovative products in development covering major valvular diseases and next-generation technologies. As of August 19, 2022, the Group has four BD projects, which are deployed in the fields of aortic valve replacement for AR, mitral valve replacement, tricuspid valve replacement and mitral valve coaptation augmentation, respectively. In addition to BD projects, its internally developed projects are also widely recognized. Areas of the Group are exploring include improving the durability of prosthetic valves, creating non-implant treatment solution for valve diseases and developing innovative mitral valve repair products.Among them, three projects are entering into significant clinical trial stages: GeminiOne(R) and MonarQ will enter the registration clinical trial and overseas FIM clinical trial stages, respectively, and HighLife(R) will enter the registration clinical trial stage.Neurointerventional Business: With the Group's successive launch of four ischemic products, the product portfolio for the ischemic product line has been preliminarily established. The Group are able to provide a complete set of solutions for hemorrhagic and ischemic strokes. With increasing sales from hemorrahagic products and upcoming commercialization of recently approved ischemic products, the revenue composition of the Neurointerventional Business will further diversify. In the first half of 2022, the registration applications of four products have been approved by the NMPA, namely, Syphonet(R) Stent Retriever, Tethys AS(R) Aspiration Catheter, Fastunnel(R) Delivery Balloon Dilation Catheter and Fluxcap(R) Balloon Guide Catheter. The product portfolio for the ischemic product line has been preliminarily established, with all major devices readily in place, forming a complete solution for patients with AIS and ICAD.As of now, for the Neurointerventional Business, the Group had fourteen registered products and seven product candidates at various development stages. The Group have a comprehensive portfolio of registered and pipeline products that target both hemorrhagic and ischemic stroke markets, providing one-stop solution for both hemorrhagic and ischemic strokes with a complete line of core products. This will not only build its resilience in times of change and uncertainty, but also enhance the attractiveness and synergy of its product portfolio among physicians and distributors. Thanks to the superior product performance, strong marketing capability as well as stable and in-depth distributor network, revenue from the Neurointerventional Business increased by 57.6% during the period, as compared to the same period in 2021. The revenue generated from the sales of hemorrhagic, ischemic and vascular access products accounted for 44.2%, 25.0% and 30.6% of the total revenue of the Neurointerventional Business, respectively. With increasing sales from hemorrahagic products and upcoming commercialization of recently approved ischemic products, the revenue composition of its Neurointerventional Business will further diversify. As of June 30, 2022, the Group had 177 distributors, covering more than 1,800 hospitals in 31 provinces nationwide. The Group will continue to build on its sales team and distributor coverage in response to its expanding ischemic product portfolio. As of June 30, 2022, the Group had a sales and marketing team of 74 employees focusing on the sales and marketing of neurointerventional products. As of June 30, 2022, the Group had a robust intellectual property portfolio, consisting of a total of 89 granted and valid patents and 100 patents under application. Specifically, there are 53 granted and valid patents and 74 patents under application for our Transcatheter Valve Therapeutic Business, and 36 granted and valid patents and 26 patents under application for its Neurointerventional Business. Dr. Yi Zhang, Executive Director, Chairman of the Board and Chief Executive Officer of Peijia Medical Limited, said "As one of the world-class medical device leader rooted in China, Peijia Medical will strive to strengthen the Group's leading position in the industry by implementing a series of future strategies and plans. Looking forward, the company will continue to develop and commercialize interventional solutions for structural cardiac and neurovascular diseases in China and globally in line with its corporate vision. Meanwhile, the Group will continue to actively promote the clinical trials of pre-clinical products in development, and try our best to bring positive and effective treatment options to patients as soon as possible." Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

Taiwan Rides on Post-Pandemic Wave with Taiwan Food World GO Project, Boosting Market Growth in SEA Market

August 18, 2022

SINGAPORE, Aug 18, 2022 - (ACN Newswire via SEAPRWire.com) - As the world progressively leaves the pandemic behind, Taiwan's Ministry of Economic Affairs (MOEA) has joined hands with Taiwan's Bureau of Foreign Trade and Taiwan External Trade Development Council (TAITRA) to ride the waves of the new era with the Taiwan Food World GO Project.The inaugural event was held at the Hilton Singapore Orchard yesterday and was live-streamed simultaneously across three countries - Korea Republic, Vietnam and Malaysia.The Taiwan Food World GO Project global event is an NT$200-million (US$6.67 million) project which incorporates a series of marketing activities, through the assistance in funding, international certifications and professional advice, to help Taiwan food manufacturers penetrate overseas markets.With the Chinese market taking up the majority of Taiwan food product sales, Taiwan plans to diversify its markets further, eyeing increased market shares in Asian, North American, European and Oceanian markets to raise export volumes, with MOEA and TAITRA hoping that this project will help Taiwanese food manufacturers reach up to 50,000 overseas consumers.The following companies showcased their popular products during the launch event:Kuang Chuan- Assam Milk Tea- Earl Grey Milk Tea- Cold Brew Fragrant Green Tea- Cold Brew Black TeaBamboo House- Four TreasuresTai Yang Tang- Tai Yang BiscuitsShu Lin Biscuit- Lins Handmade CookiesTaiwan TTL- Hua Diao Wine Chicken Noodles- Lychee Fruit BeerDu Hsiao Yue- Pork SauceZong Hong- Black Fungus DrinkOklao- Taiwan Series Drip Coffee- Musician Series Drip Coffee- World Finest Drip Coffee BundleSunny Hills Delights- Pineapple CakeMICO- French CookiesTaiSun- Mixed Congee- Oatmeal with ChestnutWei Zhe- Pineapple Nougat with BiscuitSan Shu Gong- Mango JellyHurng Fur Foods- Brown Sugar Soft Flour CakeMs. Cynthia Kiang, Director General, Bureau of Foreign Trade, MOEA, said, "Taiwanese food, especially our iconic pineapple cakes and bubble milk tea, has always been loved by foreigners. These signature food products are the national food icon of Taiwan, and a must-buy for tourists. With the residual pandemic restrictions still in place, the "Taiwan Food World GO Project" will provide an avenue for everyone around the world to have access to Taiwan's food products, safely and healthily."Following the kick-off event, TAITRA will be running a food fair in local Prime Supermarket outlets and a four-day FHA - Food & Beverage event at Singapore Expo Hall, in September 2022, featuring a wide variety of innovative food products from 24 different Taiwanese food manufacturers.Media ContactPRecious Communications for TAITRAJacqualine ChanTel: +65 6303 0567E-mail: taitra@preciouscomms.comTaiwan External Trade Development CouncilTaiwan Trade Center, SingaporeAnna Wu - Chief Representative OfficerTel: +65 6235 0369Email: singapore@taitra.org.tw Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

SKYX Achieves Historic U.S. Standardization Approval Vote – a Major Milestone Towards Mandatory Status for Safety of Consumers and Professionals

August 9, 2022

MIAMI, FL, Aug 9, 2022 - (ACN Newswire via SEAPRWire.com) - SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a "Sky Technologies") ("SKYX," "we" or "the Company"), a highly disruptive platform technology company, with over 60 issued and pending patents globally for simplifying and enhancing safety and automation in homes and buildings, today announced that its universal safe installation specifications for plug & play ceiling outlet for lighting and fan products has been officially voted on and approved by ANSI/NEMA, the leading U.S. standardization organizations for the standardization of the SKYX safe weight-bearing plug and outlet/receptacle for ceilings ("SkyPlug").The American National Standards Institute ("ANSI") is the leading U.S. standards approval organization, whose standards are regularly specified by most architects and engineers for U.S. residential and commercial buildings to ensure safety, quality and reliability. The National Electrical Manufacturers Association ("NEMA") is a standards-developing organization that promotes the standardization of major U.S. electrical products for manufacturers. The achievement of an ANSI / NEMA vote approval is a lengthy and rigorous process, widely considered to be very difficult to achieve. Examples of other products that are standardized include the wall outlet, GFCI bathroom outlet and other key products that are included in every home in the U.S.The standardization of the SKYX plug & play weight-bearing plug and outlet/receptacle for ceilings by ANSI/NEMA will universally provide SKYX's product specifications to manufacturers to help save lives, time and money for both professionals and consumers, enabling them to install light fixtures and ceiling fans with a safe plug & play installation in just minutes, if not seconds.Rani Kohen, Founder and Executive Chairman of SKYX Platforms, said: "This standardization approval vote opens the door to major sales and licensing opportunities, as well as a milestone achievement not only for SKYX, but for consumers and professionals across the nation. In today's world, I believe that consumers and professionals shouldn't have to risk their lives standing on ladders for a long time, while touching hazardous wires to install light fixtures and ceiling fans. Additionally, this is a significant development for lighting and fan companies as well as showrooms. It not only saves their customers both time and money, but enables them to safely and quickly replace light fixtures and ceiling fans, and purchase fixtures much more often for a variety of reasons - be that to match fashion trends, accommodate the changing of seasons, holidays and more."Mark Earley, former Chief Electrical Engineer at NFPA, former head of the NEC and current Chair of the SKYX Safety Advisory Board, said: "This is a significant achievement for SKYX and the safety of U.S. consumers and professionals. With hundreds of millions of installations taking place in the U.S., there are many risks associated with installing or replacing light fixtures and ceiling fans. These risks include injuries and deaths from fires, shocks, electrocutions, and falls from ladders. These risks can be reduced by using the SKYX safe plug and play installation method, that also saves installation time, which substantially reduces time spent on ladders."Bernard Zyscovich, a leading U.S. architect, internationally recognized design and thought leader, and Chair of the SKYX Architectural & Real Estate Advisory Board, said: "Having the ANSI/NEMA approval vote to include a design of a product is on top of the list for architects and engineers and a substantial deciding factor determining builders' product acceptance. As it reflects product integrity, quality and most important, safety. This achievement by SKYX's ceiling outlet receptacle and plug is ground-breaking."About SKYX Platforms Corp.As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the standard.SKYX Platforms Corp. (NASDAQ:SKYX) has a series of highly disruptive advanced-safe-smart platform technologies, with over 60 U.S. and global patents and patent pending applications. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com or follow us on LinkedIn.Cautionary Statement Concerning Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking statements. Management has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While they believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond management's control. These statements involve risks and uncertainties that may cause the Company's actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Our estimates of the addressable market for our products may prove to be incorrect. The projected demand for our products could materially differ from actual demand. Forward-looking statements speak only as of the date they are made and include statements relating to the Company's ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its smart products and technologies, including commencement of presales, the Company's efforts and ability to drive the adoption of Sky's Plug Smart Platforms into multi-family residential buildings and communities and adoption by hotels, ability to capture market share, ability to execute on any sales and licensing opportunities, ability to achieve code mandatory status for the SkyPlug, and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission. In particular, the American National Standards Institute's (ANSI) and the National Electrical Manufacturers Association's (NEMA) vote for the standardization of the Company's weight-bearing plug and outlet/receptacle for ceilings does not guarantee approval by the National Fire Protection Association's (NFPA) Committee on the National Electrical Code (which consists of multiple code-making panels and a technical correlating committee and develops the National Electrical Code (NEC)) or any other trade or regulatory organization and does not guarantee that any of the Company's products will become National Electrical Code (NEC)-code mandatory in any jurisdiction, or that any of the Company's current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all. There can be no assurance as to any of these matters. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.Investor Relations Contact:Lucas A. ZimmermanMZ North America(949) 259-4987SKYX@mzgroup.usSOURCE: SQL Technologies, Inc. dba Sky Technologies Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

Swang Chai Chuan Limited Announces Details of Proposed Listing on the Main Board of The Stock Exchange of Hong Kong Limited

August 8, 2022

HONG KONG, Aug 8, 2022 - (ACN Newswire via SEAPRWire.com) - Swang Chai Chuan Limited ("Swang Chai Chuan" or the "Group"), an established distributor of Food & Beverage ("F&B") and other products for recognised international and domestic third-party brands and own brands in Malaysia, today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX").Swang Chai Chuan plans to offer a total of 241,000,000 shares under the Global Offering (subject to the Over-allotment Option), which comprises 216,900,000 Shares (subject to re-allocation and the Over-allotment Option) for the International Placing, and 24,100,000 Shares (subject to re-allocation) for the Hong Kong Public Offering. Based on the Offer Price HK$0.54 per Share (being the mid-point of the indicative offer price range of HK$0.52 to HK$0.56 per Share) assuming the Over-allotment Option is not exercised, after deducting estimated underwriting fees and other expenses, net proceeds from the Global Offering are estimated at approximately HK$86.0 million.The Hong Kong Public Offering will commence from 9:00 a.m. on 8 August 2022 (Monday) and end at 12:00 noon on 11 August 2022 (Thursday). Results of allocations are expected to be announced on 18 August 2022 (Thursday), and dealing of the Group's shares is expected to commence on the Main Board of HKEX on 19 August 2022 (Friday) under the stock code of 2321. Shares will be traded in board lots of 5,000 Shares each. Sunny Fortune Capital Limited is the Sole Sponsor and Sunny Fortune Capital Limited and Elstone Securities Limited are the Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers. BOCOM International Securities Limited, China Galaxy International Securities (Hong Kong) Co., Limited, CMBC Securities Company Limited, Haitong International Securities Company Limited and Phillip Securities (Hong Kong) Limited are the other Joint Bookrunners and other Joint Lead Managers.Investment HighlightsEstablished F&B distributor of Own Brands, international and domestic brands in MalaysiaSwang Chai Chuan is one of the top 5 companies(1) in Malaysia F&B distribution industry. With its long years of experience in and dedication to the F&B distribution industry in Malaysia, the Group has become an established local F&B distributor with substantial scale, supporting over 200 international and domestic brands. Third-Party Brands distributed by the Group included Oreo, Cadbury, Ajinomoto, a British multinational ice-cream frozen dessert brand and a New Zealand international dairy product brand. The Group has also served a number of well-established retail chains such as Nirwana, TF Value-Mart, BS Group and Sabasun. To establish the reputation and enhance the market penetration, Swang Chai Chuan is committed to offering a wide range of products under different brands to customers with timely delivery service. At the same time, the Group has received awards and recognitions by Malaysian associations in recognition of the excellent product and services, such as the Superbrands Status and the Sin Chew Business Excellence Awards.Strong sourcing network and long-term relationship with recognised international and domestic brand ownersThe Group distributed and actively managed the diverse portfolio of F&B and other brands of a wide selection of quality products covering 4,000 SKUs, which can be divided into nine different core categories, namely dairy products, frozen food, packaged food and commodities, sauce, oil and condiments, beverages and specialty products, personal and baby care products, pet care products and cleaning and kitchen supplies. The Group has established long-term business relationship ranging from approximately 5 to 26 years with its five largest suppliers to date, thus enabling the Group to ensure a stable supply of products.Since 2007, the Group started tapping into the development of certain Own-Brand Products, the variety of which was gradually expanded. The Group was able to provide different choices of F&B and other products to the customers under over 200 Third-Party Brands, consisting of approximately 140 international brands and approximately 80 domestic brands, together with products under five major Own Brands, such as CED, Mega Fresh, Mega Food, Sayangku and Snowcat, covering various product types and price ranges. Specialty products, salt, frozen seafood, frozen meat, and pet care products, etc. under the major Own Brands further enlarged the brand and product portfolio and consumer base of the Group. The Group will continue to explore new brands and products that are expected to have growth potential and to diversify the product offerings.Large and diverse customer base with a strong focus on large retail chains and channelsThe Group has established and maintained a large customer base with more than 11,000 active customers over the years with a focus on well-established retail chains. Many of the Group's customers are established international retail chains and local retail chains which make purchases frequently and in huge quantities. As a result of the effort to diversify customer portfolio, the Group also serves F&B dealers and merchandisers, school canteens, hospitality and other customers. As at 30 April 2022, the Group had established long-term business relationship with the five largest customers during the track record period ranging from approximately 11 to 26 years. The Group achieved high customer retention rate with revenue generated from repeat customer accounts contributing over 90% of the total revenue during the track record period. With the large and diverse customer base as illustrated above, the increasing scale and complexity of the customers' business operation have driven demand for F&B products sourced from suppliers that scale up the procurement and other business activities, thereby growing the revenue. The Group also enjoys economies of scale and continues to optimise its cost structure and increase its profitability.Expansive distribution network is strategically located and well equipped with temperature-controlled facilitiesThe Group's distribution network, which form the cornerstone of warehousing and logistics management services, can effectively facilitate the supply chain of F&B distribution and deliver products to more customers on a timely basis with delivery lead time as short as within 24 hours. The Group currently operated 12 warehouses strategically located in the major sales regions in Peninsular Malaysia, with designated storage capacity of approximately 25,600 CBM, nine of which are equipped with cold storage facilities with an aggregate of approximately 4,550 CBM mainly for storage of frozen food and dairy products. The Group also operated a fleet of over 140 self-operated logistics vehicles, of which approximately 100 are refrigerated trucks, which facilitate an effective and efficient flow of warehousing and logistics management operations.Proven track record of financial performanceDuring the track record period, the gross profit margin of the Group showed an upward trend, with the gross profit margin in FY2021 reaching 14.1%. Gross profit amounted to approximately RM94.5 million (equivalent to approximately HK$181.7 million) in FY2021, representing a year-on-year increase of approximately 18.5% from FY2020. Adjusted net profit also rose by approximately 29.9% year-on-year from FY2020 to approximately RM28.6 million (equivalent to approximately HK$54.9 million) in FY2021. (2)RM'000(approximately) FY2019 FY2020 FY2021 4M2022(As at 30 April)Revenue 497,435 564,632 668,738(equivalent to approximately HK$1,286,035) 266,652(equivalent to approximately HK$512,792)Gross profit 66,187 79,733 94,508(equivalent to approximately HK$181,746) 38,753(equivalent to approximately HK$74,525)Gross profit margin 13.3% 14.1% 14.1% 14.5%Adjusted net profit* 17,686 21,985 28,562(equivalent to approximately HK$54,927) 13,556(equivalent to approximately HK$26,069)Adjusted net profit margin* 3.6% 3.9% 4.3% 5.1%* Adjusted net profit was calculated based on the profit for the year excluding listing expenses during the track record periodDuring the track record period, the Group recorded ongoing growth in revenue, gross profit and adjusted net profit. At the same time, gross profit margin and adjusted net profit margin also continued to rise.Experienced and dedicated senior management teamThe Group has an experienced, dedicated and capable management team led by the executive Directors, the Soon Brothers, who have been instrumental in spearheading the growth of the Group and have over 30 years of experience in the business of distribution of F&B products in Malaysia. They are responsible for the overall business strategy, planning, operational and sales management and development of the Group. In addition, the Group has a loyal, experienced and capable senior management team with extensive operational expertise and in-depth understanding of the F&B distribution industry in Malaysia and is able to establish a high degree of product differentiation and a broad brand portfolio.Future Growth StrategiesFurther enhancing distribution and sales capabilities by investing in cold chain and other infrastructureDuring the track record period, the Group's revenue generated from frozen food and dairy products represented approximately 50% of the total revenue. Both frozen food and dairy products are sold by the Group under, in addition to Third-Party Brands, Own Brands or on a White-Label basis which generally have a higher profit margin as compared to the distribution and sales of Third-Party Brand Products. Going forward, the primary business strategies of the Group should pivot around enhancing the cold chain warehousing and logistics capabilities and management. The Group plans to (i) set up a new warehouse with cold storage facilities and upgrade the self-owned warehouses with advanced features; (ii) acquire and upgrade cold and other logistics vehicles; (iii) enhance cold chain and other management and information systems.Apart from cold storage facilities, the expected increase in designated general storage capacity would also facilitate the optimisation of the storage space and enhance the efficiency in sales of the products that are stored under general condition and improve the operational results.Enhanced development of Own ProductsOwn Products and White-Label Products generally enjoy a high gross profit margin, which drives the expansion of relevant segments. The Group plans to develop the business of the Own Products and White-Label Products by purchasing new processing machines for processing so as to take up more orders, save labour costs and enhance processing efficiency. The Group will also conduct marketing and promotional activities of the Own-Brand Products to further conduct media marketing and engage with more potential customers.Development of e-commerce business by launching a mobile applicationOwing to the large and diverse customer base with more than 11,000 active customers, the Group receives and processes a large number of orders from various types of customers every day. To streamline the ordering process and in line with the market trend, the Group plans to develop the e-commerce operations by engaging an external party service provider to design and customise a mobile application. The Ordering App is expected to be launched and put into use by the fourth quarter of FY2023 and it is expected to create a more convenient and pleasant purchasing experience for customers and enhance the efficiency of the Group.Strategic acquisitions and investments along the supply value chainIn view of the expected growth in the F&B distribution industry in Malaysia, the Group plans to continue to expand the business and explore potential business opportunities by acquiring majority or entire shareholding of, or investing in, local company(ies) or acquiring business(es) in the F&B supply value chain, including horizontal and vertical acquisitions and investments.Use of proceedsBased on the Offer Price of HK$0.54 per Share (being the mid-point of the indicative Offer Price range of HK$0.52 to HK$0.56 per Share) and assuming the Over-allotment Option is not exercised, after deducting estimated underwriting fees and other expenses, net proceeds from the Global Offering are estimated at approximately HK$86.0 million. The Group currently intends to use the net proceeds from the Global Offering for the following manner:Applications / Percentage-- To further enhance the distribution and sales capabilities by investing in cold chain and other infrastructure 47.8%-- To develop the Own Products business by acquiring new processing machines and conducting marketing and promotional activities 18.0%-- To develop e-commerce business by launching a mobile application 7.0%-- For strategic acquisitions and investments along the supply value chain 17.2%-- As general working capital 10.0%Cornerstone InvestmentThe Group has entered into cornerstone investment agreements with four cornerstone investors separately, namely Mr. Tee Kian Heng, Huihuang Resources Limited, Dato' Sri Ng Chong Keong and Dato' Sri Pek Kok Sam (each a "Cornerstone Investor" and together the "Cornerstone Investors"), pursuant to which the Cornerstone Investors have agreed to, subject to certain conditions, subscribe for such number of Shares (rounded down to the nearest board lot of 5,000 Shares) at the Offer Price, which may be purchased with an aggregate amount of approximately HK$47.0 million. The Group believes that introducing the Cornerstone Investors to the Global Offering and securing the subscription of a significant number of Offer Shares will set a solid platform for the launch of the Global Offering by demonstrating the Cornerstone Investors' confidence in the Global Offering.Swang Chai Chuan LimitedSwang Chai Chuan Limited is one of the top 5 companies* in Malaysia F&B distribution industry and is an established distributor of F&B and other products for recognised international and domestic third-party brands and own brands. Swang Chai Chuan Limited also provides suppliers with warehousing, logistics, sales and marketing support and other value-added services* In terms of revenue in 2021, according to Frost & SullivanCapitalised terms used herein shall have the same meanings as those defined in the prospectus dated 8 August 2022, unless the context otherwise requires.Media enquiries:Strategic Financial Relations LimitedVeron Ng Tel: (852) 2864 4831 Email: veron.ng@sprg.com.hkMel Lai Tel: (852) 2864 4855 Email: mel.lai@sprg.com.hkAggie Fang Tel:(852) 2114 4987 Email: aggie.fang@sprg.com.hkNotes:(1) In terms of revenue in 2021, according to Frost & Sullivan(2) These amounts are converted from Malaysian Ringgit to Hong Kong dollars or Hong Kong dollars to Malaysian Ringgit at an exchange rate of RM0.52 to HK$1.00. No representation is made that Malaysian Ringgit/Hong Kong dollars amount have been, could have been or may be converted to Hong Kong dollars/Malaysian Ringgit at that rate or at all.Important:1. This press release is for information purposes only and does not constitute or include any recommendation or invitation or offer (nor is calculated to invite such a recommendation, offer or invitation) by any person for acquisition, purchase or subscription of the securities of the Company nor does it intend to act as a recommendation of the sale of securities or any invitation or offer for acquisition, purchase or subscription of securities. This press release should accordingly not amount to an advertisement or invitation within the meaning of section 103(1) of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) or a prospectus or an extract from or abridged version of a prospectus within the meaning of sections 2 and 38B, respectively of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Investors should read the prospectus of the Company for detailed information about the Company and the proposed offering before deciding whether or not to purchase any securities of the Company. An application to subscribe for the shares referred to in this press release by any persons shall be made solely based on the prospectus and the application forms to be issued by the Company on 8 August 2022. 2. No application for the shares of the Company should be made by any person nor would such application be accepted without the completion of a formal application form or other application procedure that is issued with or in respect of the prospectus.3. The directors of the Company collectively and individually accept full responsibility for the accuracy of the information contained in this press release and confirm, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts the omission of which would make any statement herein misleading. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

KOHLER, together with Lazada Singapore, to bring 30 leading lifestyle brands under one roof in month-long online to offline shopping experience

July 21, 2022

SINGAPORE, Jul 21, 2022 - (ACN Newswire via SEAPRWire.com) - KOHLER, a global lifestyle brand and leader in kitchen and bath products, has partnered with Lazada Singapore to bring 30 complementary leading lifestyle brands together for the first time, to provide online shoppers with a curated showcase of luxurious home, kitchen, bath, and lifestyle products they can experience in-store. Come Home to KOHLER & Friends (Powered by Lazada) utilises Lazada's powerful e-commerce platform to complete the shopping experience and is aimed at satisfying changing consumer habits post-pandemic.Thematic spaces featuring various ranges of KOHLER's products, complemented by 29 participating brands at Come Home to KOHLER & Friends (Powered by Lazada) - Photo by KohlerAll the 30 lifestyle brands coming together for the first time for Come Home to KOHLER & Friends (Powered by Lazada)The month-long event will provide consumers with a unique immersive in-store feel to the digital shopping experience and offer a one-stop solution for shoppers to experience all 30 brands side by side in real-life home settings. KOHLER and the other 29 brands will showcase their curated range of products at the KOHLER Experience Centre (KEC) from 15 July to 15 August 2022.The 822 sqm KEC occupying two units of shophouses along Peck Seah Street will house several thematic spaces featuring various ranges of KOHLER's innovative, intuitive, and immersive products, complemented by participating brands such as Samsung, Bang & Olufsen, LEGO, L'OCCITANE, Razer, Nespresso, OSIM, Tefal, WMF, and Philips Lighting. The curated showcase is perfect for first-time homeowners looking for inspiration for their new home or existing homeowners looking to refresh various areas of their homes. Shoppers can explore the different themes throughout multiple levels of KEC and view dedicated spaces such as the living room, bedroom, study, kitchen, and bathroom.Each themed bathroom and living space are thoughtfully furnished by Kohler designers and representatives from the other brands. As soon as shoppers are inspired by any product they see, they can scan QR codes to purchase on the Lazada app. This means that shoppers can fully immerse themselves in these dedicated home spaces, check out and enquire about the products on display, purchase online immediately, and head home to wait for their items to arrive. This is the future of shopping."We are collaborating with Lazada to provide online customers with what they want - an immersive online to offline (O2O) shopping environment to have a real-life experience of how our products feel, look and work, and ask questions for an informed purchase," said Leo Leong, General Manager, Kohler Kitchen & Bath Group, North and Southeast Asia. "This is further complemented by our partnering brands which have collaborated with us to showcase their products in this new experience. Not just that, shoppers can enjoy online prices of up to 60% off during the fair and shopping benefits through the LazMall pages with peace of mind knowing that the products purchased are 100% authentic, with *free returns!"At KEC, shoppers will also be treated to freebies and giveaways and the opportunity to register for cooking and home interior decor workshops on selected dates available for booking in person. During Come Home to KOHLER & Friends (Powered by Lazada), the KEC is opened to the public from 15 July to 15 August 2022, daily from 10am to 9pm, including Sundays.*Free shipping and return policies vary with brands and sellers.Notes to EditorsCome Home to KOHLER & Friends (Powered by Lazada)15 July to 15 August 2022KOHLER Experience Centre52/54 Peck Seah Street, Singapore 079320Tel: 6224 0039Lazada URL: https://bit.ly/KOHLERFriendsMedia Images can be downloaded here https://tinyurl.com/tav95en2Featured Kohler products on sale(1) More than 50% off Veil Dual Flush Two-Piece Toilet - $846 (U.P. $1,782)(2) 50% off Family Care Bathroom Furniture - $1,002 (U.P. $2,004)(3) 20% off Moxie Handshower, sound by Harman Kardon - $399 (U.P. $499)(4) 45% off Malleco Touchless Pull-down Kitchen Faucet - $873 (U.P. $1,587)(5) 50% off KOHLER Malleco Single Kitchen Sink - $690 (U.P. $1,368)Check out other amazing offers on display by other participating leading lifestyle brands.Giveaways/promotions during Come Home to KOHLER & Friends (Powered by Lazada)- The top 10 spenders stand to win amazing prizes from KOHLER, OSIM or Bang & Olufsen worth more than $8,000. (Minimum spending of $800 is required to qualify)- Spin & Win - Shoppers who spend a minimum of $80 during the fair will stand a chance to win Manchester United premiums.- Sing For Sale - Sing your heart out and enjoy 40% off Moxie Handshower, sound by Harman Kardon from only $299 (U.P. $499)Activities & WorkshopsSessions are free. Please register 15 mins before each workshop at KEC.- Cooking Workshop with Chef Ivan Yeo with Food Tasting; Dates: Saturday, 30 July 2022; Time: 4pm to 6pm- Home Interior Seminar by Bowerman Interior; Date: Sunday, 7 Aug 2022; Time: 3pm to 4pmAbout Kohler Co.Founded in 1873 and headquartered in Kohler, Wisconsin, Kohler Co. is one of America's oldest and largest privately held companies, with more than 35,000 associates. With more than 50 manufacturing locations worldwide, Kohler is a global leader in the design, innovation and manufacture of kitchen and bath products; engines and power systems; luxury cabinetry and tile; and owner/operator of two five-star hospitality and golf resort destinations in Kohler, Wisconsin, and St. Andrews, Scotland. The company also develops solutions to address pressing issues, such as clean water and sanitation, for underserved communities around the world to enhance the quality of life for current and future generations. For more details, please visit KOHLER.SG.About KOHLER on LazMallAs part of KOHLER's mission of providing a higher level of gracious living for those touched by our products and services, KOHLER's online store on LazMall offers our customers another convenient way to shop for our quality and innovative kitchen and bath products. With over 100 products ranging from toilet, lavatory, faucet, bathroom furniture, bathroom accessories, and kitchen sink and faucet available online to choose from, our customers can be assured that our products are 100% authentic, with 15-day easy returns and free delivery. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Proex, the Leading Multi-Contract Exchange, Secures MSB Licensing Across the U.S. And Canada

July 19, 2022

New York, NY, July 19, 2022 – (SEAPRWire) – During the first quarter of 2020, ProEx, the leading multi-contract exchange, launched with the vision of offering seamless crypto trading solutions and services to users specific to the South East Asian region. With time, the exchange recorded phenomenal growth, securing Money Service Business operators licensing from the United States and Canada. With the licensing, ProEx now has the potential to rival the traditional crypto trading platforms and banking system by providing features to help crypto traders of all regions to perform all their activities and needs on the platform. Since the development of blockchain-based digital assets and cryptocurrencies, the crypto industry has been marketed as an alternative to replacing the existing financial system in the future. However, to access such products, traders can only allocate capital in cryptocurrencies through decentralized and centralized exchanges that offer secure marketplaces for trading and exchanging digital assets. Unfortunately, most regional exchanges, in particular, lack proper security protocols, legal compliances, and auditing. ProEx facilitates its users by ensuring security and safety, high liquidity, convenience of use, and superior benefits when compared with the current crypto exchanges while also ensuring maximum trading products and services for portfolio diversification that includes but is not limited to Spot Trading, Futures Trading, ETF Leverage trading, and Contract Trading. The exchange further ensures seamless crypto trading through maximum throughput, no transactional delays, and multi-app support. The CEO and Director of ProEx, Mr. Allan Zhang, said: “We are excited to share with our community that ProEX has obtained the MSB (Money Services Business) license in the United States and Canada. United States MSB license is strictly audited and issued by The Financial Crimes Enforcement Network (FinCEN), a bureau of the U.S. Department of the Treasury. Our registration numbers are: USA MSB Registration number: 31000167334309 Canada MSB Registration number: M20105184 “With this achievement, ProEX is committed to launching more innovative derivative products and services to create a better trading environment for its customers while also having the potential to expand its outreach across the globe.” continued Mr. Allan Zhang. He further said, “our objective with the ProEx platform is to make it easier for both old and new crypto inventors to explore the market in a safe environment. ProEx will work towards releasing the true power of digital finance by creating a blockchain-based ecosystem where digital assets can thrive.” The CTO, said, “The team at E.Z. Exchange has gone through this trial by fire and has experienced the difficulties and stresses of navigating through different exchanges and trading cryptocurrencies. While we managed to develop a multi-contract trading platform, expansion to new regions was crucial for us to develop further. For that, with the U.S. and Canada MSB registration, we’ve designed, and are building, the best cryptocurrency exchange in the world by explicitly identifying and addressing the issues beleaguering the current cryptocurrency trading environment. Our unique and innovative solutions put traders first, ensuring that users never again deal with a substandard customer or user experience when trading cryptocurrency and that I believe will help us become the leading multi-contract exchange of the world.” The leadership team at ProEx consists of experts from various fields with AAA-rated KYC and AML/APG (Asia/Pacific Group on Money Laundering). The management system has over 20 years of experience in the banking sector HSBC and Standard Chartered SCB. The exchange platform has an existing user base of over 500,000 active traders. It’s a trusted brand that sets industry standards regarding security and compliance. About ProEx ProEx is the world’s leading multi-contract trading platform serving crypto users since 2020. That is committed to offering innovative trading products and services for a better trading environment. It gives users a variety of crypto products and solutions, including but not limited to derivatives, spot trading, futures, leveraged ETFs, and contract trading. https://www.proex.io/en_US/ Social Links Facebook: https://www.facebook.com/ProExvn Twitter: https://twitter.com/exchangepro_ Media Contact Company: ProEx Contact: Julette Lee Email: marketing@proex.io Website: https://www.proex.io SOURCE: ProEx The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)

ACN Newswire

IBO Technology Achieves Turnaround in FY2021/22 Annual Results

July 3, 2022

HONG KONG, Jul 3, 2022 - (ACN Newswire via SEAPRWire.com) - IBO Technology Company Limited ("IBO Technology" or the "Company", together with its subsidiaries, the "Group"; Stock Code: 2708.HK) is pleased to announce its consolidated annual results for the year ended 31 March 2022 (the "financial year" or the "Year"). During the Year, thanks to the rapid development of its principal businesses, the Group was able to achieve a business turnaround. IBO Technology's three main businesses are 5G (communication equipment and private network solutions), Information Technology Application Innovation ("ITAI") IT (terminal products and industry solutions) and Internet of Things ("IoT") (products and solutions), and is committed to providing quality one-stop 5G, ITAI and IoT products and solutions. During the Year, thanks to the recovery in economic activities and the expansion of customer base, the Group delivered accelerated growth and achieved business turnaround. Its revenue amounted to approximately RMB1,046.30 million, representing a year-on-year surge of 86.7% from approximately RMB560.33 million in the previous year. The gross profit of the Group increased by 53.9% to approximately RMB178.60 million (FY2020/21: approximately RMB116.02 million), while the gross profit margin was 17.1% (FY2020/21: 20.7%). The profit attributable to owners of the Company for the financial year was approximately RMB14.66 million, as compared to loss attributable to owners of the Company of approximately RMB42.10 million in FY2020/21. The basic earnings per share for the financial year was approximately RMB2.67 cents, as compared to the basic loss per share of approximately RMB9.81 cents in the previous year.Capitalising on favourable policies in ITAI industry and industry digitisation to achieve business growthFrom the "13th Five-Year Plan" to the "14th Five-Year Plan", the Central and local governments have been developing the "digital economy" and building "Digital China" as their important objectives, clarifying the "Digital China" construction strategy and seizing the high ground of the digital economy production chain. The governments at all levels are strongly promoting the development of the ITAI industry, facilitating the development of various fields within the industry and driving the transformation of the traditional IT information industry.With the rapid growth of China's ITAI industry and its penetration into various fields, key core technologies have been researched and developed domestically to foster original innovations. The Central and local governments have made great efforts to promote the ITAI procurement, and are determined to increase the proportion of ITAI product applications, which have begun to enter key industry markets such as finance, telecommunications and energy. The enlarged scale of procurement for domestically-produced equipment as well as software and hardware by all levels, coupled with the expanding market size, have reflected that replacement by domestic production has entered a substantive stage. Riding on the "14th Five-Year Plan" policies, the Group has been proactively growing its ITAI business, which is divided into direct sales and Original Design Manufacturer ("ODM") channels according to its sales model, and actively participating in proprietary tendering to accelerate the launch of its products which have been widely recognised.Striding into harvesting period as intelligent terminal products sales and software development businesses achieved significant breakthroughIntelligent terminal products sales business remained the Group's main revenue source, accounting for 85.2% of the total revenue for the financial year. During the Year, the Group focused on the development, production and sales of customised IoT smart terminals for its customers, mainly including notebooks, tablets, all-in-one PCs, desktop PCs, and industrial gateway servers. Benefiting from the recovery of economic activities and the favourable policies of the ITAI industry at the national level, coupled with the orders of ITAI IT products signed earlier by the Group were gradually delivered to customers, the revenue from the sales of intelligent terminal products increased significantly. During the Year, the intelligent terminal products sales business recorded a revenue of approximately RMB891.37 million, representing a significant increase of approximately 121.7% and the growth driver of the Group.In respect of software development business, the Group planned and designed the software system frameworks and function lists for customers, and provided customised software application development services based on their business and management needs. The software development business accounted for 10.0% of the Group's total revenue. Leveraging its strong software development capabilities, the Group has been providing quality software application development services to serve customers in different industries for many years. In addition to maintaining long-term and strategic relationships with existing customers, the Group also actively explores new customers to expand its customer base and drive sales. During the Year, as a result of the continued expansion of its software development business and its customer base, the Group recorded revenue of approximately RMB104.23 million (FY2020/21: RMB45.49 million), representing a significant year-on-year increase of approximately 129.1%.With regards to system integration business, based on the analysis and assessment of customers' needs, the Group provides customers with integrated and customised system solutions based on IoT and related technologies. In view that the revenue of the systems integration business is derived from one-off projects with fluctuating revenue as compared to other segments, the Group's systems integration business shrank during the financial year, with revenue slightly dipped to approximately RMB39.82 million (FY2020/21: approximately RMB101.00 million), accounting for 3.8% of the Group's total revenue.For system maintenance services business, the Group provides software and hardware system maintenance services for information systems, including system equipment maintenance and management, database maintenance, daily system monitoring and system upgrade, etc. During the Year, attributable to its business optimisation and adjustment, the Group's system maintenance services business decreased slightly to approximately RMB10.88 million (FY2020/21: approximately RMB11.83 million), accounting for 1.0% of the Group's total revenue.Accelerating the launch of products and riding on the favourable policies to promote exponential growth of the Group's businessRiding on the "14th Five-Year Plan" policies, the Group has been proactively expanding its ITAI business and actively participated in proprietary tendering to accelerate the launch of its products. During the Year, the purely domestically-produced notebook computers designed and developed by the Group have entered the market and have been widely recognised. The Group will accelerate the development of the ITAI industry as well as the research and development of products, striving to gain more market share as the Group's purely domestically-produced ITAI IT products are expected to become the growth engine of the Group's future results. While continuously improving its products, the Group will enhance its marketing and promotion efforts for ITAI IT products, and cooperate with industry partners to promote the sales of ITAI IT products of the Group and accelerate the rapid popularisation and promotion of replacement by domestic production in various industries.As a leading industry digital solutions provider, the Group has collaborated with a number of large state-owned enterprises and private enterprises through different projects and gained extensive project experience in the field of 5G private network. Looking ahead, the Group will build on its successful experience in previous projects and its solid foundation in the industry, as well as the synergies generated with enterprise partners in various aspects such as technology, supply chain and market to organise research and pilot testing for 5G private networks, to optimise the key stages ranging from application to deployment, in order to provide the best quality solutions to operators and industry partners.Mr. LAI Tse Ming, Chairman and Executive Director of IBO Technology, said, "Our three business segments are closely interconnected and synergistic in terms of underlying technologies, application technologies, supply chains, projects and business models. We strive to integrate and innovate the 5G, ITAI and IoT technologies to form new business models and industrial ecologies, so as to effectively leverage our advantages and integrated technological capabilities to maximise overall value created. In addition, we will actively identify suitable merger and acquisition targets that create strong synergies with our existing principal businesses to support our operations and rapid development. Leveraging the Group's accumulated technologies and strong market demand, our three principal businesses are expected to generate significant synergies, which will contribute to the exponential growth of the Group's overall business development. Going forward, the management will continue to seek breakthroughs and strive to create long-term and stable returns for our investors and shareholders."About IBO Technology Company LimitedIBO Technology Company Limited (Stock code: 2708.HK), a leading digital solutions provider, is principally engaged in providing 5G communication equipment and private network solutions, ITAI terminal products and industry solutions, IoT products and solutions, as well as industrial digital solutions in the PRC. The Group's businesses mainly cover four areas, namely (i) intelligent terminal products sales; (ii) system integration; (iii) software development; and (iv) system maintenance services. With nearly 20 years penetration in the IoT industry, the Group serves customers from both the public and private sectors in the PRC, including government authorities, large-scale state-owned enterprises and private enterprises.For more details, please visit: http://www.ibotech.hk/ Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

Dynasty Fine Wines Announces Product Upgrades in 2022, Invigorates its Brands with More New Products Young and Chic

June 20, 2022

HONG KONG, Jun 20, 2022 - (ACN Newswire via SEAPRWire.com) - Dynasty Fine Wines Group Limited ("Dynasty" or the "Group") (stock code: 00828), a premium grape winemaker in China, has upgraded its products in 2022, launching two smaller volume - 373ml and 180ml - wine series in screw cap bottles, and also the Pleasant Color gift box and "Chinese style" product series, offering consumers more new and fashionable products and also to capture share in the young consumer market.Innovative small 373ml and 180ml screw cap productsPleasant Color gift box setThe new "Chinese style" series with the Chinese name of Dynasty on the bottle The Group has launched the innovative 373ml and 180ml Dynasty dry red and semi-dry white series, sizes "disruptive" of the traditional wine market, to help it tap the young consumer market. Unlike the traditional 750ml bottles the Group offers, the new products come with the screw cap to make them more convenient to enjoy, and young people today like to enjoy their wines anytime, anywhere. Of the two new products, intending to snatch a piece of the market from beer, the 180ml comes in boxes of six, giving young people another choice of drinks in gatherings. As for the 373ml series, it promises added value to consumers. With O2O platform support, consumers can scan the product QR code and get rewards, not only helping foster interaction between consumers and the brand, but also giving consumers direct benefits and surprises, and ultimately allowing Dynasty's products to reach wider consumer groups.A grape wine series of entry-level prices, Pleasant Color targets to appeal to young consumers and has been well received since its debut last year. This year, a gift box has been created for it, a gift option ideal for gatherings with family and friends and festive celebrations. In addition, the ready-to-drink series for young consumers, pairs well with hot pot, fusion and private kitchen dishes, thus is popular among young people. With such attributes and support of new media marketing on including Xiaohongshu, Douyin, Kuaishou and Weibo, the series has become a hot choice on the Internet.Dynasty's products typically carry on the bottle the "DYNASTY" brand name. To strengthen brand awareness, the Group has launched a "Chinese style" edition showing its name in Chinese, to bring home its position as a domestic grape wine brand and also to attract mainstream e-commerce consumers who love what China makes and favors. Dynasty plans to promote the series via e-commerce channels and, on top of presence on mainstream e-commerce platforms, efforts will be made to exploit new retail channels using such supplementary promotional means as live streaming or videos.In recent years, Dynasty has been actively pursuing innovation, embracing the "5+4+N" product strategy, with "N" standing for developing various customized products and continuously creating new products to meet the diverse needs of different Chinese consumer groups. The Group's product upgrade in 2022 entailing the launch of new products more convenient to enjoy, young and chic, and agreeing with the crave for all things China, can help invigorate the brand, strengthen the deployment of products for young consumers, as well as consolidate the image of Dynasty as a representative domestic grape wine brand. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia

June 15, 2022

HONG KONG, Jun 15, 2022 - (ACN Newswire via SEAPRWire.com) - Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group), "Jacobson Group"; stock code: 2633.HK) and JBM (Healthcare) Limited ("JBM", together with its subsidiaries, "JBM Group"; stock code: 2161.HK) jointly announced today on forming Ban Loong Jacobson JBM Pharma Limited (the "Joint Venture") to capture the growth opportunities of the specialty pharmaceuticals and branded healthcare markets in Greater China and the Asia-Pacific region.Back row: From left to right: Mr. Tang Ming, Chief Executive Officer of Ban Loong and Mr. Yim Chun Leung, Executive Director of Jacobson & Non-executive Director of JBM witness the signing ceremony; Front row: From left to right: Mr. Liu Zhouyang, Executive Director & Deputy Chief Executive Officer of Ban Loong and Mr. Yu Chun Kau, Chief Financial Officer of Jacobson sign the Joint Venture AgreementThe Joint Venture, which is owned 60% by Ban Loong, 20% by Jacobson and 20% by JBM respectively, will principally engage in the in-licensing of specialty pharmaceuticals (including orphan drugs), over-the-counter medicines, branded healthcare products (including herb-based products) and medical devices, and the sales and distribution of the products to Greater China and selected markets in Asia, alongside tapping merger and acquisition opportunities with a strategic fit. Leveraging the partner companies' respective market knowhow, capabilities and network, the Joint Venture is aimed at establishing a strong foothold and realizing tangible business opportunities available in the high-growth specialty pharmaceuticals, branded healthcare products and medical device markets in the aforementioned regions.Mr. Tang Ming, Chief Executive Officer of Ban Loong, said, "In light of the promising growth of the pharmaceutical, healthcare and medical device markets in Greater China and the Asia-Pacific region, coupled with the increased awareness of personal healthcare in the post-pandemic era, there is a substantial market potential for the Joint Venture to capture. Indeed, a strong growth forecast is also expected in the next few years, with an average annual growth rate of over 9% in the pharmaceutical and healthcare markets in China. We are excited with the strategic partnership with Jacobson and JBM in expanding our healthcare trading portfolio and riding on our synergetic strengths to seize and realize the opportunities in the markets."Mr. Raymond Yim, Executive Director of Jacobson, said, "We are very honored to partner with Ban Loong and aspire to strengthen our foothold through the Joint Venture in Greater China and markets in Asia. In line with our market expansion strategy, the Joint Venture will facilitate and enhance our access to the specialty drugs, branded healthcare products and medical devices markets in the regions, as well as generate cross-selling synergies for respective partner's products marketed and distributed through the Joint Venture platform. "About Ban Loong Holdings Limited (Stock Code: 0030)Ban Loong Holdings Limited is an internationalized healthcare products trading company with its business presence covering Greater China and key Asian markets including Japan, South Korea and ASEAN countries, as an authorized general agent for branded products from the United States, Switzerland and other European Union firms, Ban Loong possesses a wide range of well-selected healthcare products in its portfolio. For more details about Ban Loong, please visit the Group's website: http://0030.com.hkAbout Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated and engaged in the research, development, production, sale and distribution of essential medicines and specialty drugs. As a major provider of generic drugs in Hong Kong, the Group has one of the most extensive sales and distribution coverage for both the private and public sectors in Hong Kong, with an expanding reach into strategically selected Asian markets. Carrying a broad product portfolio and taking a pre-eminent market position in a number of therapeutic categories, the Group operates a host of 10 PIC/S GMP licensed production facilities for generic drugs in Hong Kong.The Group aims at the continued strategic enrichment of its generic drug portfolios through the addition of high-value-added products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan, Singapore and Cambodia, forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.comAbout JBM (Healthcare) Limited (Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries. The Group is a unique field player with marketing expertise and a drug heritage that prioritizes product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines and health and wellness products, which include well-recognized household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex, BITE-X, Mederma Kids, Tong Tai Chung Woodlok Oil, Flying Eagle Woodlok Oil, Saplingtan and Shiling Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

1 2